申请人:Rexahn Pharmaceuticals, Inc.
公开号:US20170014411A1
公开(公告)日:2017-01-19
The disclosed subject matter provides methods using and kits comprising a compound of formula (I)
or a hydrate, a solvate, or a pharmaceutically acceptable salt thereof. The disclosed subject matter further provides a method of treating one or more symptoms of cancer comprising administering to a subject in need thereof a compound of formula (I) and a process for preparing such.